Figure 7. The K02288 scaffold is similar to an anti-malarial compound.

(A) The 2-aminopyridine scaffold of K02288. (B) A similar initial hit 1 was identified in a recent anti-malarial screen and optimized to the more divergent lead 2 in development of the pre-clinical candidate MMV390048 [34].